CYP2D6 in the brain: genotype effects on resting brain perfusion

Area of Science:

• Neuroscience
• Pharmacogenomics
• Neuroimaging

Background:

• Cytochrome P450 2D6 (CYP2D6) is a polymorphic enzyme crucial for metabolizing psychoactive drugs.
• CYP2D6 is expressed in various brain regions, including the hippocampus, thalamus, hypothalamus, and cortex, but its brain function remains unclear.
• CYP2D6 may play a physiological role in neurotransmitter biotransformation within the brain.

Purpose of the Study:

• To investigate the functional role of CYP2D6 in the brain.
• To examine the relationship between CYP2D6 genetic variations and brain perfusion levels at rest.
• To explore CYP2D6's potential involvement in regulating emotional reactivity and fear detection.

Main Methods:

• CYP2D6 genotyping was performed in 188 healthy individuals.
• Brain perfusion levels at rest were measured and compared across different CYP2D6 metabolizer groups.
• Statistical analyses were used to assess correlations between CYP2D6 genotype and regional brain perfusion.

Main Results:

• Poor metabolizers of CYP2D6 showed significantly higher thalamic perfusion levels (15% increase) compared to extensive metabolizers.
• These effects were observed in the whole sample and when stratified by CYP2D6 activity levels.
• A trend for increased perfusion was noted in the right hippocampus, and exploratory analysis suggested involvement in alertness and serotonergic pathways.

Conclusions:

• The study provides evidence supporting a functional role for CYP2D6 in the human brain.
• CYP2D6 genetic variations are associated with differences in brain perfusion, particularly in the thalamus.
• These findings highlight the potential impact of CYP2D6 pharmacogenetics on brain function and emotional processing.